PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Webinar - 6.30am tomorrow, page-53

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    PR appears (at least to me) to be losing touch with specifics associated with PAR based on the last couple of interviews he has given, where he has stated a couple of things that were wrong. I no longer have full confidence that enough of his attention is on PAR at the most crucial time in PARs development phase. I also have low confidence that PAR will be able to successfully navigate any setbacks that may arise over the next few months should PR remain as the leader of two ASX-listed companies.

    To me, PR seems more invested in NSB right now and the science that underpins their products, which he will have to learn in order to try to get them through their current mess. NSB's resubmission probably won't take place until September, so does PR intend to remain as interim CEO beyond the initial 3-6 months as first reported to the market? This certainly doesn't look good for PAR that's for sure.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.